Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20,932 | 21,214 | 20,723 | 21,279 | 21,160 |
| Receivables | 12,068 | 10,154 | 11,194 | 10,334 | 10,982 |
| Inventories | 9,965 | 10,709 | 8,902 | 10,075 | 10,130 |
| Other current assets | 2,700 | 2,966 | 3,555 | 0 | 0 |
| TOTAL | $45,665 | $45,043 | $44,374 | $45,591 | $44,974 |
| Non-Current Assets | |||||
| PPE Net | 1,059 | 936 | 1,127 | 1,266 | 1,294 |
| Intangibles | 178,802 | 186,984 | 195,018 | 202,267 | 217,857 |
| Other Non-Current Assets | 1,292 | 1,192 | 1,133 | 1,211 | 2,503 |
| TOTAL | $181,153 | $189,112 | $197,278 | $204,744 | $221,654 |
| Total Assets | $226,818 | $234,155 | $241,652 | $250,335 | $266,628 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 12,056 | 12,306 | 13,056 | 14,306 | 12,000 |
| Accounts payable and accrued liabilities | 12,925 | 13,238 | 11,591 | 12,103 | 12,837 |
| Other current liabilities | 490 | N/A | 1,887 | 255 | 10,272 |
| TOTAL | $31,533 | $30,398 | $31,190 | $31,175 | $39,688 |
| Non-Current Liabilities | |||||
| Long Term Debt | 81,065 | 82,057 | 83,279 | 84,268 | 78,450 |
| Other Non-Current Liabilities | 1,831 | 2,006 | 817 | 2,148 | 2,545 |
| TOTAL | $83,849 | $84,866 | $85,144 | $87,714 | $82,541 |
| Total Liabilities | $115,382 | $115,264 | $116,334 | $118,889 | $122,229 |
| Shareholders' Equity | |||||
| Common Shares | 264,761 | 265,165 | 265,206 | 265,629 | 266,007 |
| Retained earnings | -164,606 | -155,388 | -148,449 | -140,903 | -135,206 |
| Other shareholders' equity | -2,870 | -5,167 | -5,260 | -6,605 | 973 |
| TOTAL | $111,436 | $118,891 | $125,318 | $131,446 | $144,399 |
| Total Liabilities And Equity | $226,818 | $234,155 | $241,652 | $250,335 | $266,628 |